tert-Butyl 8-azabicyclo[3.2.1]octan-3-ylcarbamate

Catalog No. :
ACMVZG593
CAS No. :
287114-25-4
Molecular Formula :
C12H22N2O2
Molecular Weight :
226.32

IUPAC Name:tert-butyl (8-azabicyclo[3.2.1]octan-3-yl)carbamate

tert-Butyl 8-azabicyclo[3.2.1]octan-3-ylcarbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$75.00Login to see priceIn stockInquiry
250mg98%$113.00Login to see priceIn stockInquiry
1g98%$278.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 8-azabicyclo[3.2.1]octan-3-ylcarbamate
IUPAC Nametert-butyl (8-azabicyclo[3.2.1]octan-3-yl)carbamate
MDL No.MFCD18083814
Molecular FormulaC12H22N2O2
Molecular Weight226.32
SMILESC12CCC(CC(C1)NC(OC(C)(C)C)=O)N2
InChI KeyUUHPKKKRSZBQIG-UHFFFAOYSA-N
Synonym3-(Boc-aMino)-8-azabicyclo[3.2.1]octane;tert-Butyl 8-azabicyclo[3.2.1]octan-3-ylcarbamate, >=97%;tert-Butyl 8-aza-bicyclo[3.2.1]octan-3-ylcarbamate;TERT-BUTYL 8-AZABICYCLO[3.2.1]OCT-3-YLCARBAMATE;Carbamic acid, N-8-azabicyclo[3.2.1]oct-3-yl-, 1,1-dimethylethyl ester;3-tert-butoxyaminodemethyltropane
CAS No.287114-25-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACMVZG593 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDHYP952 route compound structure diagram
    ACDHYP9521415560-32-5 In Stock
  4. Then
  5. ACMVZG593 route product structure diagram
    ACMVZG593287114-25-4 In Stock
Inquiry

2. ACMVZG593 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMVZG593 route product structure diagram
    ACMVZG593287114-25-4 In Stock
Inquiry

Comments (0)